Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial

被引：0
|
作者：
Adeniyi Olagunju
Adeola Fowotade
Ajibola Olagunoye
Temitope Olumuyiwa Ojo
Bolanle Olufunlola Adefuye
Adeniyi Francis Fagbamigbe
Akindele Olupelumi Adebiyi
Omobolanle Ibitayo Olagunju
Olabode Taiwo Ladipo
Abdulafeez Akinloye
Babatunde Ayodeji Adeagbo
Adedeji Onayade
Oluseye Oladotun Bolaji
Christian Happi
Steve Rannard
Andrew Owen
机构：
[1] Obafemi Awolowo University,Department of Pharmaceutical Chemistry, Faculty of Pharmacy
[2] University of Liverpool,Department of Molecular and Clinical Pharmacology
[3] University of Ibadan,Department of Medical Microbiology and Parasitology, College of Medicine
[4] State Specialist Hospital,Department of Community Health, Faculty of Clinical Sciences
[5] Obafemi Awolowo University Teaching Hospital,Department of Epidemiology and Medical Statistics, Faculty of Public Health
[6] Olabisi Onabanjo University Teaching Hospital,Department of Community Medicine
[7] University of Ibadan,Department of Surveillance and Epidemiology
[8] University of Ibadan,African Centre of Excellence for Genomics of Infectious Diseases
[9] Nigeria Centre for Disease Control,Department of Chemistry, School of Physical Sciences
[10] Oyo State Ministry of Health,undefined
[11] Redeemer’s University,undefined
[12] University of Liverpool,undefined
来源：
Trials | / 22卷
关键词：
COVID-19; SARS-CoV-2; nitazoxanide; atazanavir/ritonavir; randomised controlled trial; protocol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial
    Olagunju, Adeniyi
    Fowotade, Adeola
    Olagunoye, Ajibola
    Ojo, Temitope Olumuyiwa
    Adefuye, Bolanle Olufunlola
    Fagbamigbe, Adeniyi Francis
    Adebiyi, Akindele Olupelumi
    Olagunju, Omobolanle Ibitayo
    Ladipo, Olabode Taiwo
    Akinloye, Abdulafeez
    Adeagbo, Babatunde Ayodeji
    Onayade, Adedeji
    Bolaji, Oluseye Oladotun
    Happi, Christian
    Rannard, Steve
    Owen, Andrew
    TRIALS, 2021, 22 (01)
  • [2] Evaluation of the efficacy and safety of inhaled magnesium sulphate in combination with standard treatment in patients with moderate or severe COVID-19: A structured summary of a study protocol for a randomised controlled trial
    Pourdowlat, Guitti
    Mousavinasab, Seyed Ruhollah
    Farzanegan, Behrooz
    Kashefizadeh, Alireza
    Meybodi, Zohreh Akhoundi
    Jafarzadeh, Maedeh
    Baniasadi, Shadi
    TRIALS, 2021, 22 (01)
  • [3] Evaluation of the efficacy and safety of inhaled magnesium sulphate in combination with standard treatment in patients with moderate or severe COVID-19: A structured summary of a study protocol for a randomised controlled trial
    Guitti Pourdowlat
    Seyed Ruhollah Mousavinasab
    Behrooz Farzanegan
    Alireza Kashefizadeh
    Zohreh Akhoundi Meybodi
    Maedeh Jafarzadeh
    Shadi Baniasadi
    Trials, 22
  • [4] Treatment with Hydroxychloroquine vs Hydroxychloroquine plus Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial
    Meneses Calderon, Jose
    Mendieta Zeron, Hugo
    Padmanabhan, Srivatsan
    TRIALS, 2020, 21 (01)
  • [5] Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
    Emadi, Ashkan
    Chua, Joel V.
    Talwani, Rohit
    Bentzen, Soren M.
    Baddley, John
    TRIALS, 2020, 21 (01)
  • [6] Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
    Ashkan Emadi
    Joel V. Chua
    Rohit Talwani
    Søren M. Bentzen
    John Baddley
    Trials, 21
  • [7] The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
    Rahimi, Arash
    Samimagham, Hamid Reza
    Azad, Mehdi Hassani
    Hooshyar, Dariush
    Arabi, Mohsen
    KazemiJahromi, Mitra
    TRIALS, 2021, 22 (01)
  • [8] The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
    Arash Rahimi
    Hamid Reza Samimagham
    Mehdi Hassani Azad
    Dariush Hooshyar
    Mohsen Arabi
    Mitra KazemiJahromi
    Trials, 22
  • [9] A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial
    Mohammad Bosaeed
    Ebrahim Mahmoud
    Mohammad Hussein
    Ahmad Alharbi
    Abdulrahman Alsaedy
    Adel Alothman
    Majed Aljeraisy
    Hajar Alqahtani
    Marwan Nashabat
    Badriah Almutairi
    Manar Almaghaslah
    Omar Aldibasi
    Sameera AlJohani
    Abderrezak Bouchama
    Yaseen Arabi
    Ahmad Alaskar
    Trials, 21
  • [10] A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial
    Bosaeed, Mohammad
    Mahmoud, Ebrahim
    Hussein, Mohammad
    Alharbi, Ahmad
    Alsaedy, Abdulrahman
    Alothman, Adel
    Aljeraisy, Majed
    Alqahtani, Hajar
    Nashabat, Marwan
    Almutairi, Badriah
    Almaghaslah, Manar
    Aldibasi, Omar
    AlJohani, Sameera
    Bouchama, Abderrezak
    Arabi, Yaseen
    Alaskar, Ahmad
    TRIALS, 2020, 21 (01)
12345